Bromo-PEG3-bromide|cas:31255-26-2|西域试剂

Bromo-PEG3-bromide,98.08%

产品编号：Bellancom-141373| CAS NO：31255-26-2| 分子式：C₈H₁₆Br₂O₃| 分子量：320.02

Bromo-PEG3-bromide 是一种 PROTAC linker，属于 PEG 类。可用于合成 PROTAC 分子。

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用，

货号	价格	库存与货期
Bellancom-141373	￥200.00	杭州北京（现货）
Bellancom-141373	￥300.00	杭州北京（现货）
Bellancom-141373	￥400.00	杭州北京（现货）

增值税发票√顺丰快递√订货电话：18601927057

Bromo-PEG3-bromide

产品介绍

Bromo-PEG3-bromide 是一种 PROTAC linker，属于 PEG 类。可用于合成 PROTAC 分子。

生物活性

Bromo-PEG3-bromide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

体外研究

PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究

性状

Liquid

溶解性数据

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Pure form	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

参考文献

. An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 [Content Brief]

化学品安全说明书(MSDS)

下载MSDS

质检证书(COA)

产品编号(Item Number)

批号(Lot Number)

相关产品

112-60-7

~88%

31255-26-2

文献：Biron, Eric; Otis, Francois; Meillon, Jean-Christophe; Robitaille, Martin; Lamothe, Julie; Van Hove, Patrick; Cormier, Marie-Eve; Voyer, Normand Bioorganic and Medicinal Chemistry, 2004 , vol. 12, # 6 p. 1279 - 1290

112-60-7

603-35-0

~68%

31255-26-2

791-28-6

文献：Hurley, Christopher A.; Wong, John B.; Ho, Jimmy; Writer, Michele; Irvine, Scott A.; Lawrence, M. Jayne; Hart, Stephen L.; Tabor, Alethea B.; Hailes, Helen C. Organic and Biomolecular Chemistry, 2008 , vol. 6, # 14 p. 2554 - 2559

37860-51-8

~66%

31255-26-2

文献：Breyholz, Hans-Joerg; Wagner, Stefan; Faust, Andreas; Riemann, Burkhard; Hoeltke, Carsten; Hermann, Sven; Schober, Otmar; Schaefers, Michael; Kopka, Klaus ChemMedChem, 2010 , vol. 5, # 5 p. 777 - 789

55400-73-2

31255-26-2

文献：Rabouin, Daniel; Perron, Valerie; N'Zemba, Blaise; C.-Gaudreault, Rene; Berube, Gervais Bioorganic and Medicinal Chemistry Letters, 2003 , vol. 13, # 3 p. 557 - 560 Title/Abstract Full Text View citing articles Show Details Berube, Gervais; Rabouin, Daniel; Perron, Valerie; N'Zemba, Blaise; Gaudreault, Rene-C.; Parent, Sophie; Asselin, Eric Steroids, 2006 , vol. 71, # 10 p. 911 - 921

75-21-8

54509-73-8

31255-26-2

文献：Nesmejanow et al. Izvestiya Akademii Nauk SSSR, Seriya Khimicheskaya, 1951 , p. 708,709 Chem.Abstr., 1952 , p. 7514

123-91-1

5414-19-7

31255-10-4

31255-26-2

文献：Delaney, Paul A.; Johnstone, Robert A. W.; Entwistle, Ian D. Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1986 , p. 1855 - 1860

上游产品 7
112-60-7 603-35-0 37860-51-8 55400-73-2
75-21-8 54509-73-8 123-91-1
下游产品 9
929-75-9 99314-01-9 133494-40-3 53914-95-7
101187-39-7 31255-17-1 31255-14-8 14098-44-3
36839-56-2

[1]. An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562

Bromo-PEG3-bromide,98.08%

Bromo-PEG3-bromide

化学品安全说明书(MSDS)

质检证书(COA)

在线咨询